Inactive Ingredient Search for Approved Drug Products
Search Names Beginning with E
Inactive Ingredient | Route | Dosage Form | CAS Number | UNII | Maximum Potency per unit dose | Maximum Daily Exposure (MDE) | Record Updated |
---|---|---|---|---|---|---|---|
EDETATE CALCIUM DISODIUM | INFILTRATION | INJECTION, SOLUTION | 6766876 | 25IH6R4SGF | 0.01%w/v | ||
EDETATE CALCIUM DISODIUM | INTRA-ARTERIAL | INJECTION | 6766876 | 25IH6R4SGF | 25mg | ||
EDETATE CALCIUM DISODIUM | INTRA-ARTERIAL | INJECTION, SOLUTION | 6766876 | 25IH6R4SGF | 25mg | ||
EDETATE CALCIUM DISODIUM | INTRAMUSCULAR | INJECTION | 6766876 | 25IH6R4SGF | 0.05%w/v | ||
EDETATE CALCIUM DISODIUM | INTRATHECAL | INJECTION | 6766876 | 25IH6R4SGF | 2.16mg | ||
EDETATE CALCIUM DISODIUM | INTRAVASCULAR | INJECTION | 6766876 | 25IH6R4SGF | 100mg | ||
EDETATE CALCIUM DISODIUM | INTRAVASCULAR | INJECTION, SOLUTION | 6766876 | 25IH6R4SGF | 108mg | ||
EDETATE CALCIUM DISODIUM | INTRAVENOUS | INJECTION | 6766876 | 25IH6R4SGF | 25mg | ||
EDETATE CALCIUM DISODIUM | INTRAVENOUS | INJECTION, SOLUTION | 6766876 | 25IH6R4SGF | 108mg | ||
EDETATE CALCIUM DISODIUM | INTRAVESICAL | SOLUTION | 6766876 | 25IH6R4SGF | 0.11mg | ||
EDETATE CALCIUM DISODIUM | ORAL | CAPSULE | 6766876 | 25IH6R4SGF | NA | ||
EDETATE CALCIUM DISODIUM | ORAL | CAPSULE, EXTENDED RELEASE | 6766876 | 25IH6R4SGF | NA | ||
EDETATE CALCIUM DISODIUM | ORAL | CONCENTRATE | 6766876 | 25IH6R4SGF | 0.25mg/1ml | ||
EDETATE CALCIUM DISODIUM | ORAL | DROPS | 6766876 | 25IH6R4SGF | NA | ||
EDETATE CALCIUM DISODIUM | ORAL | ELIXIR | 6766876 | 25IH6R4SGF | 5mg/5ml | ||
EDETATE CALCIUM DISODIUM | ORAL | POWDER, FOR SOLUTION | 6766876 | 25IH6R4SGF | 0.22mg | ||
EDETATE CALCIUM DISODIUM | ORAL | POWDER, FOR SUSPENSION | 6766876 | 25IH6R4SGF | NA | ||
EDETATE CALCIUM DISODIUM | ORAL | SUSPENSION | 6766876 | 25IH6R4SGF | NA | ||
EDETATE CALCIUM DISODIUM | ORAL | TABLET | 6766876 | 25IH6R4SGF | 4mg | ||
EDETATE CALCIUM DISODIUM | ORAL | TABLET, FILM COATED | 6766876 | 25IH6R4SGF | 0.4mg | ||
EDETATE CALCIUM DISODIUM | ORAL | TABLET, ORALLY DISINTEGRATING | 6766876 | 25IH6R4SGF | 0.78mg | ||
EDETATE CALCIUM DISODIUM | SUBCUTANEOUS | INJECTION | 6766876 | 25IH6R4SGF | 5mg | ||
EDETATE CALCIUM DISODIUM | SUBCUTANEOUS | INJECTION, SOLUTION | 6766876 | 25IH6R4SGF | 0.06%w/v | ||
EDETATE CALCIUM DISODIUM | TOPICAL | OINTMENT | 6766876 | 25IH6R4SGF | NA | ||
EDETATE CALCIUM DISODIUM | TOPICAL | SOLUTION | 6766876 | 25IH6R4SGF | 0.01%w/v | ||
EDETATE CALCIUM DISODIUM | URETHRAL | SOLUTION | 6766876 | 25IH6R4SGF | 0.01%w/v | ||
EDETATE CALCIUM DISODIUM ANHYDROUS | INTRA-ARTERIAL | INJECTION | 62339 | 8U5D034955 | 23mg | ||
EDETATE CALCIUM DISODIUM ANHYDROUS | INTRAVASCULAR | INJECTION, SOLUTION | 62339 | 8U5D034955 | 0.05%w/v | ||
EDETATE CALCIUM DISODIUM ANHYDROUS | INTRAVENOUS | INJECTION | 62339 | 8U5D034955 | 23mg | ||
EDETATE DISODIUM | AURICULAR (OTIC) | DROPS | 6381926 | 7FLD91C86K | 0.05%w/w | ||
EDETATE DISODIUM | AURICULAR (OTIC) | SOLUTION | 6381926 | 7FLD91C86K | 0.1%w/v | ||
EDETATE DISODIUM | AURICULAR (OTIC) | SUSPENSION | 6381926 | 7FLD91C86K | 0.01%w/v | ||
EDETATE DISODIUM | AURICULAR (OTIC) | SUSPENSION/ DROPS | 6381926 | 7FLD91C86K | 0.01%w/v | ||
EDETATE DISODIUM | INFILTRATION | INJECTION | 6381926 | 7FLD91C86K | 0.1mg | ||
EDETATE DISODIUM | INTRA-ARTICULAR | INJECTION | 6381926 | 7FLD91C86K | 0.05%w/v | ||
EDETATE DISODIUM | INTRABURSAL | INJECTION | 6381926 | 7FLD91C86K | 0.01%w/v | ||
EDETATE DISODIUM | INTRACARDIAC | INJECTION | 6381926 | 7FLD91C86K | 2mg | ||
EDETATE DISODIUM | INTRALESIONAL | INJECTION | 6381926 | 7FLD91C86K | 0.05%w/v | ||
EDETATE DISODIUM | INTRAMUSCULAR | INJECTION | 6381926 | 7FLD91C86K | 10%w/v | ||
EDETATE DISODIUM | INTRAMUSCULAR | INJECTION, SOLUTION | 6381926 | 7FLD91C86K | 4mg | ||
EDETATE DISODIUM | INTRAVASCULAR | INJECTION | 6381926 | 7FLD91C86K | 0.48mg | ||
EDETATE DISODIUM | INTRAVENOUS | INJECTION | 6381926 | 7FLD91C86K | 10%w/v | ||
EDETATE DISODIUM | INTRAVENOUS | INJECTION, EMULSION | 6381926 | 7FLD91C86K | 0.5mg | ||
EDETATE DISODIUM | INTRAVENOUS | INJECTION, POWDER, FOR SOLUTION | 6381926 | 7FLD91C86K | 6mg | ||
EDETATE DISODIUM | INTRAVENOUS | INJECTION, POWDER, FOR SUSPENSION | 6381926 | 7FLD91C86K | 0.4mg | ||
EDETATE DISODIUM | INTRAVENOUS | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 6381926 | 7FLD91C86K | 19mg | ||
EDETATE DISODIUM | INTRAVENOUS | INJECTION, SOLUTION | 6381926 | 7FLD91C86K | 7mg | ||
EDETATE DISODIUM | INTRAVENOUS | LIQUID | 6381926 | 7FLD91C86K | 0.03%w/v | ||
EDETATE DISODIUM | INTRAVENOUS | SOLUTION | 6381926 | 7FLD91C86K | 0.05%w/v | ||
EDETATE DISODIUM | IONTOPHORESIS | SYSTEM | 6381926 | 7FLD91C86K | 0.1mg | ||
EDETATE DISODIUM | NASAL | DROPS | 6381926 | 7FLD91C86K | 0.1mg/1ml | ||
EDETATE DISODIUM | NASAL | LIQUID | 6381926 | 7FLD91C86K | 2mg/1ml | ||
EDETATE DISODIUM | NASAL | SOLUTION | 6381926 | 7FLD91C86K | 100mg/100ml | ||
EDETATE DISODIUM | NASAL | SPRAY | 6381926 | 7FLD91C86K | 1mg | ||
EDETATE DISODIUM | NASAL | SPRAY, METERED | 6381926 | 7FLD91C86K | 4mg | ||
EDETATE DISODIUM | OPHTHALMIC | DROPS | 6381926 | 7FLD91C86K | 0.05%w/v | ||
EDETATE DISODIUM | OPHTHALMIC | EMULSION | 6381926 | 7FLD91C86K | 0.3%w/v | ||
EDETATE DISODIUM | OPHTHALMIC | GEL | 6381926 | 7FLD91C86K | 396mg | ||
EDETATE DISODIUM | OPHTHALMIC | SOLUTION | 6381926 | 7FLD91C86K | 0.13%w/v | ||
EDETATE DISODIUM | OPHTHALMIC | SOLUTION/ DROPS | 6381926 | 7FLD91C86K | 0.1%w/v | ||
EDETATE DISODIUM | OPHTHALMIC | SUSPENSION | 6381926 | 7FLD91C86K | 0.06%w/v | ||
EDETATE DISODIUM | OPHTHALMIC | SUSPENSION/ DROPS | 6381926 | 7FLD91C86K | 1mg | ||
EDETATE DISODIUM | ORAL | CAPSULE | 6381926 | 7FLD91C86K | 5mg | ||
EDETATE DISODIUM | ORAL | CONCENTRATE | 6381926 | 7FLD91C86K | 10mg | ||
EDETATE DISODIUM | ORAL | ELIXIR | 6381926 | 7FLD91C86K | 1.3mg/5ml | ||
EDETATE DISODIUM | ORAL | LIQUID | 6381926 | 7FLD91C86K | 0.5mg/1ml | ||
EDETATE DISODIUM | ORAL | POWDER, FOR SUSPENSION | 6381926 | 7FLD91C86K | 3mg/5ml | ||
EDETATE DISODIUM | ORAL | SOLUTION | 6381926 | 7FLD91C86K | 420mg | ||
EDETATE DISODIUM | ORAL | SUSPENSION | 6381926 | 7FLD91C86K | 18mg | ||
EDETATE DISODIUM | ORAL | SUSPENSION, EXTENDED RELEASE | 6381926 | 7FLD91C86K | 40mg | ||
EDETATE DISODIUM | ORAL | SUSPENSION/ DROPS | 6381926 | 7FLD91C86K | 4mg | ||
EDETATE DISODIUM | ORAL | SYRUP | 6381926 | 7FLD91C86K | 40mg | ||
EDETATE DISODIUM | ORAL | TABLET | 6381926 | 7FLD91C86K | 100mg | ||
EDETATE DISODIUM | ORAL | TABLET, CHEWABLE | 6381926 | 7FLD91C86K | 1mg | ||
EDETATE DISODIUM | ORAL | TABLET, COATED | 6381926 | 7FLD91C86K | 0.21mg | ||
EDETATE DISODIUM | ORAL | TABLET, DELAYED RELEASE | 6381926 | 7FLD91C86K | 100mg | ||
EDETATE DISODIUM | ORAL | TABLET, EFFERVESCENT | 6381926 | 7FLD91C86K | 32mg | ||
EDETATE DISODIUM | ORAL | TABLET, EXTENDED RELEASE | 6381926 | 7FLD91C86K | 10mg | ||
EDETATE DISODIUM | ORAL | TABLET, FILM COATED | 6381926 | 7FLD91C86K | 4mg | ||
EDETATE DISODIUM | ORAL | TABLET, ORALLY DISINTEGRATING | 6381926 | 7FLD91C86K | 3mg | ||
EDETATE DISODIUM | RECTAL | AEROSOL, FOAM | 6381926 | 7FLD91C86K | 2mg | ||
EDETATE DISODIUM | RECTAL | ENEMA | 6381926 | 7FLD91C86K | 60mg | ||
EDETATE DISODIUM | RECTAL | SOLUTION | 6381926 | 7FLD91C86K | 97mg | ||
EDETATE DISODIUM | RESPIRATORY (INHALATION) | SOLUTION | 6381926 | 7FLD91C86K | 1mg | ||
EDETATE DISODIUM | RESPIRATORY (INHALATION) | SPRAY | 6381926 | 7FLD91C86K | 0.05%w/w | ||
EDETATE DISODIUM | RESPIRATORY (INHALATION) | SUSPENSION | 6381926 | 7FLD91C86K | 0.01%w/v | ||
EDETATE DISODIUM | SOFT TISSUE | INJECTION | 6381926 | 7FLD91C86K | 0.05%w/v | ||
EDETATE DISODIUM | SUBCUTANEOUS | INJECTION | 6381926 | 7FLD91C86K | 6mg | ||
EDETATE DISODIUM | SUBCUTANEOUS | INJECTION, SOLUTION | 6381926 | 7FLD91C86K | 2mg | ||
EDETATE DISODIUM | TOPICAL | AEROSOL, FOAM | 6381926 | 7FLD91C86K | 0.05%w/w | ||
EDETATE DISODIUM | TOPICAL | CREAM | 6381926 | 7FLD91C86K | 14mg | ||
EDETATE DISODIUM | TOPICAL | CREAM, AUGMENTED | 6381926 | 7FLD91C86K | 2mg | ||
EDETATE DISODIUM | TOPICAL | EMULSION | 6381926 | 7FLD91C86K | 0.11%w/w | ||
EDETATE DISODIUM | TOPICAL | GEL | 6381926 | 7FLD91C86K | 7mg | ||
EDETATE DISODIUM | TOPICAL | LOTION | 6381926 | 7FLD91C86K | 4mg | ||
EDETATE DISODIUM | TOPICAL | OINTMENT | 6381926 | 7FLD91C86K | 0.01%w/w | ||
EDETATE DISODIUM | TOPICAL | SHAMPOO | 6381926 | 7FLD91C86K | 1%w/w | ||
EDETATE DISODIUM | TOPICAL | SHAMPOO, SUSPENSION | 6381926 | 7FLD91C86K | 1%w/w | ||
EDETATE DISODIUM | TOPICAL | SOLUTION | 6381926 | 7FLD91C86K | 1mg | ||
EDETATE DISODIUM | TOPICAL | SYSTEM | 6381926 | 7FLD91C86K | 126mg | ||
EDETATE DISODIUM | TRANSDERMAL | GEL | 6381926 | 7FLD91C86K | 0.06%w/w | ||
EDETATE DISODIUM | VAGINAL | CREAM | 6381926 | 7FLD91C86K | 2mg | ||
EDETATE DISODIUM | VAGINAL | GEL | 6381926 | 7FLD91C86K | 5mg | ||
EDETATE DISODIUM ANHYDROUS | INTRAMUSCULAR | INJECTION | 139333 | 8NLQ36F6MM | 0.01%w/v | ||
EDETATE DISODIUM ANHYDROUS | INTRAVENOUS | INJECTION | 139333 | 8NLQ36F6MM | 3mg | ||
EDETATE DISODIUM ANHYDROUS | ORAL | SOLUTION | 139333 | 8NLQ36F6MM | 0.5mg | ||
EDETATE DISODIUM ANHYDROUS | TOPICAL | CREAM | 139333 | 8NLQ36F6MM | 0.02%w/w | ||
EDETATE DISODIUM ANHYDROUS | VAGINAL | CREAM | 139333 | 8NLQ36F6MM | 0.05%w/w | ||
EDETATE SODIUM | INTRAMUSCULAR | INJECTION | 64028 | MP1J8420LU | 0.01%w/v | ||
EDETATE SODIUM | INTRAVENOUS | INJECTION | 64028 | MP1J8420LU | 0.01%w/v | ||
EDETATE SODIUM | INTRAVENOUS | INJECTION, SOLUTION | 64028 | MP1J8420LU | 0.04%w/v | ||
EDETATE SODIUM | OPHTHALMIC | EMULSION | 64028 | MP1J8420LU | 0.02%w/w | ||
EDETATE SODIUM | OPHTHALMIC | SOLUTION | 64028 | MP1J8420LU | 0.1%w/v | ||
EDETATE SODIUM | ORAL | CAPSULE | 64028 | MP1J8420LU | 1mg | ||
EDETATE SODIUM | ORAL | TABLET | 64028 | MP1J8420LU | 5mg | ||
EDETATE SODIUM | TOPICAL | LOTION | 64028 | MP1J8420LU | 0.17%w/w | ||
EDETATE SODIUM | TOPICAL | SHAMPOO | 64028 | MP1J8420LU | 1.33%w/w | ||
EDETATE SODIUM | TOPICAL | SOAP | 64028 | MP1J8420LU | 0.12%w/w | ||
EDETATE SODIUM | TOPICAL | SOLUTION | 64028 | MP1J8420LU | 0.3%w/w | ||
EDETATE SODIUM | TOPICAL | SPONGE | 64028 | MP1J8420LU | 0.14%w/w | ||
EDETATE TRISODIUM | TOPICAL | CREAM | 150389 | 420IP921MB | NA | ||
EDETIC ACID | AURICULAR (OTIC) | SUSPENSION | 60004 | 9G34HU7RV0 | NA | ||
EDETIC ACID | INTRAMUSCULAR | INJECTION, SOLUTION | 60004 | 9G34HU7RV0 | 0.02%w/v | ||
EDETIC ACID | INTRAVENOUS | INJECTION, SOLUTION | 60004 | 9G34HU7RV0 | 0.02%w/v | ||
EDETIC ACID | ORAL | TABLET | 60004 | 9G34HU7RV0 | 4mg | ||
EDETIC ACID | ORAL | TABLET, FILM COATED | 60004 | 9G34HU7RV0 | 0.2mg | ||
EDETIC ACID | RECTAL | SUPPOSITORY | 60004 | 9G34HU7RV0 | 1.7mg | ||
EDETIC ACID | SUBCUTANEOUS | INJECTION, SOLUTION | 60004 | 9G34HU7RV0 | 0.02%w/v | ||
EDETIC ACID | SUBMUCOSAL | INJECTION, SOLUTION | 60004 | 9G34HU7RV0 | 0.03%w/v | ||
EDETIC ACID | TOPICAL | CREAM | 60004 | 9G34HU7RV0 | 0.5%w/w | ||
EDETIC ACID | TOPICAL | GEL | 60004 | 9G34HU7RV0 | 0.1%w/w | ||
EDETIC ACID | TOPICAL | SHAMPOO | 60004 | 9G34HU7RV0 | 0.2%w/w | ||
EDETIC ACID | TOPICAL | SOLUTION | 60004 | 9G34HU7RV0 | 0.5%w/w | ||
EDETIC ACID | TOPICAL | SUSPENSION | 60004 | 9G34HU7RV0 | 0.06%w/w | ||
EGG PHOSPHOLIPIDS | INTRAVENOUS | EMULSION | 93685906 | 1Z74184RGV | 1.2%w/v | ||
EGG PHOSPHOLIPIDS | INTRAVENOUS | INJECTION | 93685906 | 1Z74184RGV | 1.8%w/v | ||
EGG PHOSPHOLIPIDS | INTRAVENOUS | INJECTION, EMULSION | 93685906 | 1Z74184RGV | 9000mg | ||
EGG PHOSPHOLIPIDS | INTRAVENOUS | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 93685906 | 1Z74184RGV | 48.75mg | ||
EGG PHOSPHOLIPIDS | ORAL | TABLET | 93685906 | 1Z74184RGV | 48mg | ||
EIDERDOWN SOAP | ORAL | TABLET, EXTENDED RELEASE | NA | 0.39mg | |||
EMULSIFYING WAX | RECTAL | AEROSOL, FOAM | 8014388 | NA | 34mg | ||
EMULSIFYING WAX | RECTAL | AEROSOL, METERED | 8014388 | NA | 1.5%w/w | ||
EMULSIFYING WAX | TOPICAL | AEROSOL, FOAM | 8014388 | NA | 75mg | ||
EMULSIFYING WAX | TOPICAL | CREAM | 8014388 | NA | 250mg | ||
EMULSIFYING WAX | TOPICAL | LOTION | 8014388 | NA | 4%w/w | ||
EMULSIFYING WAX | TOPICAL | OINTMENT | 8014388 | NA | 1.5%w/w | ||
ENTSUFON | TOPICAL | EMULSION | 55837166 | 4HI65O1DUA | NA | ||
ENTSUFON SODIUM | TOPICAL | EMULSION | 2917944 | L6867H5FR4 | 40.3%w/w | ||
ENTSUFON SODIUM | TOPICAL | SHAMPOO | 2917944 | L6867H5FR4 | 54%w/w | ||
ENTSUFON SODIUM | TOPICAL | SPONGE | 2917944 | L6867H5FR4 | NA | ||
ERYTHORBIC ACID | ORAL | TABLET | 89656 | 311332OII1 | NA | ||
ERYTHROSINE SODIUM ANHYDROUS | ORAL | CAPSULE | 16423680 | 8TL7LH93FM | 0.01mg | ||
ERYTHROSINE SODIUM ANHYDROUS | ORAL | POWDER, FOR SUSPENSION | 16423680 | 8TL7LH93FM | 1mg | ||
ESSENCE LEMON | ORAL | SYRUP | NA | 2.5mg | |||
ESSENCE ORANGE | ORAL | SYRUP | NA | 10mg | |||
ETHYL ACETATE | ORAL | CAPSULE, EXTENDED RELEASE | 141786 | 76845O8NMZ | 382.26mg | ||
ETHYL ACETATE | ORAL | SOLUTION | 141786 | 76845O8NMZ | 13mg | ||
ETHYL ACETATE | ORAL | SUSPENSION | 141786 | 76845O8NMZ | NA | ||
ETHYL ACETATE | ORAL | TABLET, EXTENDED RELEASE | 141786 | 76845O8NMZ | NA | ||
ETHYL ACETATE | TOPICAL | SOLUTION | 141786 | 76845O8NMZ | 31%w/w | ||
ETHYL ACETATE | TRANSDERMAL | FILM, EXTENDED RELEASE | 141786 | 76845O8NMZ | 0.05mg | ||
ETHYL ACETATE | TRANSDERMAL | SYSTEM | 141786 | 76845O8NMZ | 41mg | ||
ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER (2:1; 600000 MW) | ORAL | TABLET, EXTENDED RELEASE | 9010882 | XRK36F13ZZ | 27.5mg | ||
ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER (2:1; 750000 MW) | ORAL | CAPSULE, COATED PELLETS | 9010882 | P2OM2Q86BI | 93.36mg | ||
ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER (2:1; 750000 MW) | ORAL | CAPSULE, EXTENDED RELEASE | 9010882 | P2OM2Q86BI | 187.3mg | ||
ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER (2:1; 750000 MW) | ORAL | GRANULE | 9010882 | P2OM2Q86BI | 274mg | ||
ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER (2:1; 750000 MW) | ORAL | TABLET | 9010882 | P2OM2Q86BI | 25mg | ||
ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER (2:1; 750000 MW) | ORAL | TABLET, COATED | 9010882 | P2OM2Q86BI | 66mg | ||
ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER (2:1; 750000 MW) | ORAL | TABLET, EXTENDED RELEASE | 9010882 | P2OM2Q86BI | 96.5mg | ||
ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER (2:1; 750000 MW) | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 9010882 | P2OM2Q86BI | 30mg | ||
ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER DISPERSION (2:1; 750000 MW 30% AQUEOUS) | ORAL | CAPSULE | 8NT5GK8OOD | 234mg | |||
ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER DISPERSION (2:1; 750000 MW 30% AQUEOUS) | ORAL | CAPSULE, EXTENDED RELEASE | 8NT5GK8OOD | 80mg | |||
ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER DISPERSION (2:1; 750000 MW 30% AQUEOUS) | ORAL | TABLET, EXTENDED RELEASE | 8NT5GK8OOD | 235mg | |||
ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER DISPERSION (2:1; 750000 MW 30% AQUEOUS) | ORAL | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE | 8NT5GK8OOD | 55mg | |||
ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER DISPERSION (2:1; 750000 MW 40% AQUEOUS) | ORAL | CAPSULE, EXTENDED RELEASE | 0MKJ04EU89 | 135mg | |||
ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER DISPERSION (2:1; 750000 MW 40% AQUEOUS) | ORAL | TABLET, EXTENDED RELEASE | 0MKJ04EU89 | 40mg | Y | ||
ETHYL BUTYRATE | ORAL | SOLUTION | 105544 | UFD2LZ005D | 4mg | ||
ETHYL BUTYRATE | ORAL | SUSPENSION | 105544 | UFD2LZ005D | 1mg | ||
ETHYL MALTOL | ORAL | ELIXIR | 4940118 | L6Q8K29L05 | 0.6mg/15ml | ||
ETHYL MALTOL | ORAL | POWDER, FOR SUSPENSION | 4940118 | L6Q8K29L05 | 10mg/140ml | ||
ETHYL MALTOL | ORAL | SOLUTION | 4940118 | L6Q8K29L05 | 90mg | ||
ETHYL MALTOL | ORAL | SUSPENSION, EXTENDED RELEASE | 4940118 | L6Q8K29L05 | 20mg | ||
ETHYL MALTOL | ORAL | SYRUP | 4940118 | L6Q8K29L05 | 122mg | ||
ETHYL MYRISTATE | TOPICAL | SHAMPOO | 124061 | 6995S49749 | 1%w/w | ||
ETHYL OLEATE | TOPICAL | SYSTEM | 111626 | Z2Z439864Y | 14mg | ||
ETHYL OLEATE | TRANSDERMAL | FILM, EXTENDED RELEASE | 111626 | Z2Z439864Y | 15mg | ||
ETHYL VANILLATE | ORAL | CAPSULE | 617050 | V38JK4Z93O | 0.5mg | ||
ETHYL VANILLIN | ORAL | CAPSULE | 121324 | YC9ST449YJ | 0.64mg | ||
ETHYL VANILLIN | ORAL | CAPSULE, EXTENDED RELEASE | 121324 | YC9ST449YJ | NA | ||
ETHYL VANILLIN | ORAL | PASTE | 121324 | YC9ST449YJ | 7mg | ||
ETHYL VANILLIN | ORAL | SUSPENSION | 121324 | YC9ST449YJ | 0.08mg/5ml | ||
ETHYL VANILLIN | ORAL | SYRUP | 121324 | YC9ST449YJ | NA | ||
ETHYL VANILLIN | ORAL | TABLET, CHEWABLE | 121324 | YC9ST449YJ | 0.14mg | ||
ETHYLCELLULOSE | ORAL | CAPSULE | 9004573 | 7Z8S9VYZ4B | 12.32mg | ||
ETHYLCELLULOSE | ORAL | CAPSULE, EXTENDED RELEASE | 9004573 | 7Z8S9VYZ4B | 153mg | ||
ETHYLCELLULOSE | ORAL | GRANULE, FOR SUSPENSION, EXTENDED RELEASE | 9004573 | 7Z8S9VYZ4B | NA | ||
ETHYLCELLULOSE | ORAL | POWDER | 9004573 | 7Z8S9VYZ4B | 2090mg | ||
ETHYLCELLULOSE | ORAL | POWDER, FOR SUSPENSION | 9004573 | 7Z8S9VYZ4B | NA | ||
ETHYLCELLULOSE | ORAL | SUSPENSION, EXTENDED RELEASE | 9004573 | 7Z8S9VYZ4B | NA | ||
ETHYLCELLULOSE | ORAL | TABLET | 9004573 | 7Z8S9VYZ4B | 300mg | Y | |
ETHYLCELLULOSE | ORAL | TABLET, COATED | 9004573 | 7Z8S9VYZ4B | 20mg | ||
ETHYLCELLULOSE | ORAL | TABLET, DELAYED RELEASE | 9004573 | 7Z8S9VYZ4B | 53.8mg | ||
ETHYLCELLULOSE | ORAL | TABLET, EXTENDED RELEASE | 9004573 | 7Z8S9VYZ4B | 1120mg | ||
ETHYLCELLULOSE | ORAL | TABLET, FILM COATED | 9004573 | 7Z8S9VYZ4B | 83mg | ||
ETHYLCELLULOSE | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 9004573 | 7Z8S9VYZ4B | 52.5mg | ||
ETHYLCELLULOSE | ORAL | TABLET, ORALLY DISINTEGRATING | 9004573 | 7Z8S9VYZ4B | 12mg | Y | |
ETHYLCELLULOSE | TOPICAL | CREAM | 9004573 | 7Z8S9VYZ4B | NA | ||
ETHYLCELLULOSE | TOPICAL | SYSTEM | 9004573 | 7Z8S9VYZ4B | 10mg | ||
ETHYLCELLULOSE (10 MPA.S) | ORAL | CAPSULE | 9004573 | 3DYK7UYZ62 | 39.39mg | ||
ETHYLCELLULOSE (10 MPA.S) | ORAL | CAPSULE, DELAYED RELEASE | 9004573 | 3DYK7UYZ62 | 25mg | ||
ETHYLCELLULOSE (10 MPA.S) | ORAL | CAPSULE, EXTENDED RELEASE | 9004573 | 3DYK7UYZ62 | 1754mg | ||
ETHYLCELLULOSE (10 MPA.S) | ORAL | TABLET | 9004573 | 3DYK7UYZ62 | 583mg | ||
ETHYLCELLULOSE (10 MPA.S) | ORAL | TABLET, EXTENDED RELEASE | 9004573 | 3DYK7UYZ62 | 1875mg | ||
ETHYLCELLULOSE (10 MPA.S) | ORAL | TABLET, ORALLY DISINTEGRATING | 9004573 | 3DYK7UYZ62 | 35.28mg | ||
ETHYLCELLULOSE (10 MPA.S) | TRANSDERMAL | FILM, EXTENDED RELEASE | 9004573 | 3DYK7UYZ62 | 80.4mg | ||
ETHYLCELLULOSE (100 MPA.S) | ORAL | CAPSULE, EXTENDED RELEASE | 9004573 | 47MLB0F1MV | 880mg | ||
ETHYLCELLULOSE (100 MPA.S) | ORAL | TABLET | 9004573 | 47MLB0F1MV | 9mg | Y | |
ETHYLCELLULOSE (100 MPA.S) | ORAL | TABLET, EXTENDED RELEASE | 9004573 | 47MLB0F1MV | 1323mg | ||
ETHYLCELLULOSE (20 MPA.S) | ORAL | CAPSULE | 9004573 | BJG0S321QY | 32.2mg | ||
ETHYLCELLULOSE (20 MPA.S) | ORAL | CAPSULE, COATED, EXTENDED RELEASE | 9004573 | BJG0S321QY | 36mg | ||
ETHYLCELLULOSE (20 MPA.S) | ORAL | CAPSULE, EXTENDED RELEASE | 9004573 | BJG0S321QY | 882mg | ||
ETHYLCELLULOSE (20 MPA.S) | ORAL | GRANULE | 9004573 | BJG0S321QY | 0.01mg | ||
ETHYLCELLULOSE (20 MPA.S) | ORAL | SUSPENSION, EXTENDED RELEASE | 9004573 | BJG0S321QY | 1503mg | ||
ETHYLCELLULOSE (20 MPA.S) | ORAL | TABLET, EXTENDED RELEASE | 9004573 | BJG0S321QY | 1547mg | ||
ETHYLCELLULOSE (4 MPA.S) | ORAL | CAPSULE | KC5472WRJK | 110mg | |||
ETHYLCELLULOSE (4 MPA.S) | ORAL | CAPSULE, EXTENDED RELEASE | KC5472WRJK | 50mg | |||
ETHYLCELLULOSE (4 MPA.S) | ORAL | TABLET | KC5472WRJK | 4mg | |||
ETHYLCELLULOSE (4 MPA.S) | ORAL | TABLET, CHEWABLE | KC5472WRJK | 42mg | |||
ETHYLCELLULOSE (4 MPA.S) | ORAL | TABLET, ORALLY DISINTEGRATING | KC5472WRJK | 81mg | |||
ETHYLCELLULOSE (45 MPA.S) | ORAL | CAPSULE, EXTENDED RELEASE | 9004573 | V7AD894FAZ | 1014mg | ||
ETHYLCELLULOSE (45 MPA.S) | ORAL | SUSPENSION, EXTENDED RELEASE | 9004573 | V7AD894FAZ | 50mg | ||
ETHYLCELLULOSE (45 MPA.S) | ORAL | TABLET, COATED | 9004573 | V7AD894FAZ | 48mg | ||
ETHYLCELLULOSE (45 MPA.S) | ORAL | TABLET, EXTENDED RELEASE | 9004573 | V7AD894FAZ | 715mg | ||
ETHYLCELLULOSE (50 MPA.S) | ORAL | CAPSULE, EXTENDED RELEASE | 9004573 | 6I475159RA | 1259mg | ||
ETHYLCELLULOSE (50 MPA.S) | ORAL | TABLET, DELAYED RELEASE | 9004573 | 6I475159RA | 4mg | ||
ETHYLCELLULOSE (50 MPA.S) | ORAL | TABLET, EXTENDED RELEASE | 9004573 | 6I475159RA | 158mg | ||
ETHYLCELLULOSE (50 MPA.S) | TOPICAL | SYSTEM | 9004573 | 6I475159RA | 72mg | ||
ETHYLCELLULOSE (7 MPA.S) | ORAL | CAPSULE | 9004573 | H3UP11403C | 62.13mg | ||
ETHYLCELLULOSE (7 MPA.S) | ORAL | CAPSULE, DELAYED RELEASE | 9004573 | H3UP11403C | 212mg | ||
ETHYLCELLULOSE (7 MPA.S) | ORAL | CAPSULE, EXTENDED RELEASE | 9004573 | H3UP11403C | 177mg | ||
ETHYLCELLULOSE (7 MPA.S) | ORAL | TABLET | 9004573 | H3UP11403C | 1133mg | ||
ETHYLCELLULOSE (7 MPA.S) | ORAL | TABLET, CHEWABLE | 9004573 | H3UP11403C | 106mg | ||
ETHYLCELLULOSE (7 MPA.S) | ORAL | TABLET, DELAYED RELEASE | 9004573 | H3UP11403C | 15mg | ||
ETHYLCELLULOSE (7 MPA.S) | ORAL | TABLET, EXTENDED RELEASE | 9004573 | H3UP11403C | 81mg | ||
ETHYLCELLULOSE AQUEOUS DISPERSION TYPE A | ORAL | CAPSULE | MX37N1DUF3 | 33mg | |||
ETHYLCELLULOSE AQUEOUS DISPERSION TYPE A | ORAL | CAPSULE, EXTENDED RELEASE | MX37N1DUF3 | 33mg | |||
ETHYLCELLULOSE AQUEOUS DISPERSION TYPE A | ORAL | TABLET | MX37N1DUF3 | 23mg | |||
ETHYLCELLULOSE AQUEOUS DISPERSION TYPE A | ORAL | TABLET, CHEWABLE | MX37N1DUF3 | 30mg | |||
ETHYLCELLULOSE AQUEOUS DISPERSION TYPE A | ORAL | TABLET, EXTENDED RELEASE | MX37N1DUF3 | 237mg | |||
ETHYLCELLULOSE AQUEOUS DISPERSION TYPE B | ORAL | CAPSULE | 9004573 | HZJ2V81RYU | 11.1mg | ||
ETHYLCELLULOSE AQUEOUS DISPERSION TYPE B | ORAL | CAPSULE, COATED | 9004573 | HZJ2V81RYU | 54mg | ||
ETHYLCELLULOSE AQUEOUS DISPERSION TYPE B | ORAL | CAPSULE, COATED PELLETS | 9004573 | HZJ2V81RYU | 318mg | ||
ETHYLCELLULOSE AQUEOUS DISPERSION TYPE B | ORAL | CAPSULE, DELAYED RELEASE | 9004573 | HZJ2V81RYU | 793mg | ||
ETHYLCELLULOSE AQUEOUS DISPERSION TYPE B | ORAL | CAPSULE, EXTENDED RELEASE | 9004573 | HZJ2V81RYU | 126mg | ||
ETHYLCELLULOSE AQUEOUS DISPERSION TYPE B | ORAL | GRANULE | 9004573 | HZJ2V81RYU | 118mg | ||
ETHYLCELLULOSE AQUEOUS DISPERSION TYPE B | ORAL | GRANULE, FOR SUSPENSION | 9004573 | HZJ2V81RYU | 21mg | ||
ETHYLCELLULOSE AQUEOUS DISPERSION TYPE B | ORAL | TABLET | 9004573 | HZJ2V81RYU | 2mg | ||
ETHYLCELLULOSE AQUEOUS DISPERSION TYPE B | ORAL | TABLET, CHEWABLE | 9004573 | HZJ2V81RYU | 64mg | ||
ETHYLCELLULOSE AQUEOUS DISPERSION TYPE B | ORAL | TABLET, DELAYED RELEASE | 9004573 | HZJ2V81RYU | 3mg | ||
ETHYLCELLULOSE AQUEOUS DISPERSION TYPE B | ORAL | TABLET, EXTENDED RELEASE | 9004573 | HZJ2V81RYU | 670mg | ||
ETHYLENE | ORAL | CAPSULE | 74851 | 91GW059KN7 | NA | ||
ETHYLENE GLYCOL | TOPICAL | SHAMPOO, SUSPENSION | 107211 | FC72KVT52F | 1%w/v | ||
ETHYLENE GLYCOL MONOETHYL ETHER | ORAL | CAPSULE | 110805 | IDK7C2HS09 | 0.01mg | ||
ETHYLENE OXIDE | TOPICAL | SHAMPOO | 75218 | JJH7GNN18P | 2.7%w/w | ||
ETHYLENEDIAMINE | INTRAVENOUS | INJECTION | 107153 | 60V9STC53F | 0.39%w/v | ||
ETHYLENEDIAMINE | ORAL | SOLUTION | 107153 | 60V9STC53F | 18.5mg/5ml | ||
ETHYLENEDIAMINE | TOPICAL | CREAM | 107153 | 60V9STC53F | 0.18%w/w | ||
ETHYLENEDIAMINE DIHYDROCHLORIDE | TOPICAL | CREAM | 333186 | 91WQV43244 | 0.25%w/w | ||
ETHYLENE-PROPYLENE COPOLYMER | TRANSDERMAL | FILM, EXTENDED RELEASE | NA | 31.67mg | |||
ETHYLENE-PROPYLENE COPOLYMER | TRANSDERMAL | SYSTEM | NA | 67mg | |||
ETHYLENE-VINYL ACETATE COPOLYMER (28% VINYL ACETATE) | SUBCUTANEOUS | IMPLANT | 24937788 | 8ILA5X28VS | 43mg | ||
ETHYLENE-VINYL ACETATE COPOLYMER (28% VINYL ACETATE) | VAGINAL | INSERT | 24937788 | 8ILA5X28VS | 1677mg | ||
ETHYLENE-VINYL ACETATE COPOLYMER (28% VINYL ACETATE) | VAGINAL | RING | 24937788 | 8ILA5X28VS | 1686mg | ||
ETHYLENE-VINYL ACETATE COPOLYMER (9% VINYLACETATE) | VAGINAL | INSERT | 24937788 | 4OKC630HS6 | 197mg | ||
ETHYLENE-VINYL ACETATE COPOLYMER (9% VINYLACETATE) | VAGINAL | RING | 24937788 | 4OKC630HS6 | 250.1mg | ||
ETHYLENE-VINYL ACETATE COPOLYMERS | INTRAUTERINE | SUPPOSITORY, EXTENDED RELEASE | 24937788 | NA | 160mg | ||
ETHYLENE-VINYL ACETATE COPOLYMERS | OPHTHALMIC | INSERT, EXTENDED RELEASE | 24937788 | NA | 14mg | ||
ETHYLENE-VINYL ACETATE COPOLYMERS | OPHTHALMIC | SOLUTION | 24937788 | NA | NA | ||
ETHYLENE-VINYL ACETATE COPOLYMERS | SUBCUTANEOUS | IMPLANT | 24937788 | NA | 61mg | ||
ETHYLENE-VINYL ACETATE COPOLYMERS | TRANSDERMAL | FILM | 24937788 | NA | 12mg | ||
ETHYLENE-VINYL ACETATE COPOLYMERS | TRANSDERMAL | FILM, EXTENDED RELEASE | 24937788 | NA | 735mg | ||
ETHYLHEXYL HYDROXYSTEARATE | TOPICAL | CREAM | 29383264 | B7I80BVV5E | 12%w/w | ||
ETHYLPARABEN | ORAL | GRANULE, FOR SOLUTION | 120478 | 14255EXE39 | 14mg | ||
ETHYLPARABEN | ORAL | POWDER, FOR SOLUTION | 120478 | 14255EXE39 | 13mg | ||
ETHYLPARABEN | ORAL | SOLUTION | 120478 | 14255EXE39 | 14mg | ||
ETHYLPARABEN | ORAL | SUSPENSION | 120478 | 14255EXE39 | 8mg | ||
ETHYLPARABEN SODIUM | ORAL | CAPSULE | 35285688 | Z0D00IVA10 | 1mg | ||
EUCALYPTOL | DENTAL | PASTE, DENTIFRICE | 470826 | RV6J6604TK | 2.4%w/w | ||
EUCALYPTOL | DENTAL | SOLUTION | 470826 | RV6J6604TK | NA | ||
EUCALYPTOL | NASAL | DROPS | 470826 | RV6J6604TK | 0.2mg/1ml | ||
EUCALYPTOL | NASAL | JELLY | 470826 | RV6J6604TK | 68.5mg | ||
EUCALYPTOL | NASAL | SOLUTION | 470826 | RV6J6604TK | 0.2mg/1ml | ||
EUCALYPTOL | OPHTHALMIC | DROPS | 470826 | RV6J6604TK | 0.02%w/w | ||
EUCALYPTOL | ORAL | CAPSULE | 470826 | RV6J6604TK | NA | ||
EUCALYPTUS OIL | ORAL | SYRUP | 8000484 | 2R04ONI662 | NA | ||
EXT. D&C YELLOW NO. 7 | ORAL | CAPSULE, EXTENDED RELEASE | 846708 | 08F8S9O3I5 | 0.3mg | ||
EXT. D&C YELLOW NO. 7 | ORAL | TABLET | 846708 | 08F8S9O3I5 | 5mg |
FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections: IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly
Data Through: July 3, 2024
Database Last Updated: July 31, 2024